Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib

Seminars in Hematology - United Kingdom
doi 10.1053/j.seminhematol.2009.02.003
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Elsevier BV

Related search

Bortezomib for the Treatment of Multiple Myeloma Patients

Health Technology Assessment
MedicineHealth Policy
2009English

Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells

Blood Cancer Journal
OncologyHematology
2016English

Cutaneous Myeloma and Bortezomib

Annals of Hematology
MedicineHematology
2009English

Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Productivity Costs Related to Bortezomib and Carfilzomib Administration for Multiple Myeloma in Finland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Novel Drugs for the Treatment of Multiple Myeloma

Haematologica
Hematology
2010English

Blood Distribution of Bortezomib and Its Kinetics in Multiple Myeloma Patients

Clinical Biochemistry
MedicineClinical Biochemistry
2014English

Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis

Blood Cancer Journal
OncologyHematology
2020English

A Dose Increased Once-Weekly Bortezomib-Based Combination Therapy for Multiple Myeloma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy